Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Finnish current care guideline for open-angle glaucoma.

Acta ophthalmologica·2024

Same author

Eye Injuries Caused by Wooden Projectiles in Finland.

Wilderness & environmental medicine·2022

Same author

European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment.

European journal of ophthalmology·2020

Same author

Work tool-related eye injuries: Helsinki Ocular Trauma Study.

International ophthalmology·2019

Same author

Toy gun eye injuries - eye protection needed Helsinki ocular trauma study.

Acta ophthalmologica·2018

Same author

Ring melanoma of the anterior chamber angle as a mimicker of pigmentary glaucoma.

Survey of ophthalmology·2017

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

[Drug therapy for glaucoma].

Marko Määttä¹, Päivi Puska

¹HYKS:n silmätautien klinikka, HUS.

Duodecim; Laaketieteellinen Aikakauskirja

|September 23, 2009

Summary

This summary is machine-generated.

Glaucoma drug therapy effectively lowers intraocular pressure to slow disease progression. Recent evidence shows treating normal-pressure glaucoma is also beneficial, potentially delaying onset even with high pressure but no damage.

Related Experiment Videos

Last Updated: Jun 20, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Area of Science:

Ophthalmology
Pharmacology

Context:

Glaucoma treatment traditionally focuses on lowering intraocular pressure (IOP).
High IOP cases historically benefited from drug therapy to slow disease advancement.
Recent research highlights the importance of treating normal-pressure glaucoma.

Purpose:

To review the current understanding and evidence for drug therapy in glaucoma management.
To emphasize the evolving perspective on treating normal-pressure glaucoma.
To discuss the potential of pharmacologic interventions in preventing glaucoma onset.

Summary:

Drug therapy for glaucoma is primarily aimed at reducing intraocular pressure.
Evidence now supports treating normal-pressure glaucoma, not just high-pressure cases.
Pharmacologic interventions may delay glaucoma development even before structural or functional damage occurs.

Impact:

Broadens the therapeutic approach for glaucoma patients.
Encourages earlier intervention and treatment strategies.
Improves potential outcomes and quality of life for individuals at risk of or with glaucoma.